CN102688435A - Preparation method of guiling preparation - Google Patents

Preparation method of guiling preparation Download PDF

Info

Publication number
CN102688435A
CN102688435A CN2012100744830A CN201210074483A CN102688435A CN 102688435 A CN102688435 A CN 102688435A CN 2012100744830 A CN2012100744830 A CN 2012100744830A CN 201210074483 A CN201210074483 A CN 201210074483A CN 102688435 A CN102688435 A CN 102688435A
Authority
CN
China
Prior art keywords
thick paste
preparation
preparing
volatile oil
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2012100744830A
Other languages
Chinese (zh)
Other versions
CN102688435B (en
Inventor
吴安明
严建良
吴孔松
于肖辉
黄经球
何杨虎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangxi Kangenbei tianshikang Pharmaceutical Co.,Ltd.
Original Assignee
TIANSHIKANG CHINESE MEDICINES CO Ltd JIANGXI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TIANSHIKANG CHINESE MEDICINES CO Ltd JIANGXI filed Critical TIANSHIKANG CHINESE MEDICINES CO Ltd JIANGXI
Priority to CN2012100744830A priority Critical patent/CN102688435B/en
Publication of CN102688435A publication Critical patent/CN102688435A/en
Application granted granted Critical
Publication of CN102688435B publication Critical patent/CN102688435B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a preparation method of a guiling preparation. The guiling preparation is prepared from ephedra, poppy capsule, semen armeniacae amarae (fried), semen juglandis, schisandra chinensis and round cardamom.. The invention is characterized in that the preparation method comprises the following steps of: extracting volatile oil by means of the steam distillation of the round cardamom, for later use; extracting for 2-3 times by adding medical dregs, ephedra, poppy capsule, semen juglandis and water, wherein each time is 2-4hours, merging extracting solutions, filtering, concentrating the filter liquor that each milliliter of the solution is equal to 0..8g-1.5g of crude drug, adding ethanol, so that the ethanol content reaches 35%-50%, standing, filtering, and concentrating the filter liquor to obtain thick paste, for later use; extracting the squeezed and oil-removed bitter almond and schisandra chinensis with 50%-85% ethanol for twice to three times, wherein each time is 1-3hours, merging the extracting solution, filtering, and concentrating the filter liquor to obtain thick paste, for later use; and merging the thick paste, and adding the pharmaceutically acceptable auxiliary materials, to prepare the particles, and adding the round cardamom volatile oil, to prepare the troche or the capsule, so that the guiling preparation can be prepared.

Description

A kind of method for preparing of Guiling preparation
Technical field
The present invention relates to the field of Chinese medicines, particularly a kind of method for preparing of Guiling preparation.
Background technology
Osmanthus spirit ball records in second in " the Sanitation Ministry medicine standard " Chinese traditional patent formulation preparation; It is processed by Six-element medical materials such as Herba Ephedrae, Pericarpium Papaveris, Semen Armeniacae Amarum (stir-fry), Semen Juglandis, Fructus Schisandrae Chinensis, Fructus Amomi Rotunduss; This product has the effect of convergence lung qi, relieving cough and relieving asthma, is used for treating the diseases such as work is breathed heavily, chronic cough of deficiency lung of suffering from a deficiency of the kidney.Spirit ball in osmanthus is directly pulverizing medicinal materials to be become fine powder, adds that refined honey processes again.Because spirit ball in osmanthus adopts full crude drug powder to be used as medicine, so dose is big, need take 6.5 grams at every turn, it is low also to have effective component content simultaneously, and the medicine stripping is slow, the shortcoming that bioavailability is not high, patient's poor compliance of taking medicine influences the performance of clinical drug curative effect.
Summary of the invention
The object of the present invention is to provide a kind of method for preparing of Guiling preparation, method for preparing provided by the invention is more scientific and reasonable, shows the Guiling preparation determined curative effect that the present invention makes through clinical verification.
The method for preparing of Guiling preparation provided by the invention is following:
Herba Ephedrae 400g Pericarpium Papaveris 300g Semen Armeniacae Amarum (stir-fry) 200g Semen Juglandis 200g
Fructus Schisandrae Chinensis 200g Fructus Amomi Rotundus 25g
Above Six-element medical material, Fructus Amomi Rotundus extracts volatile oil with vapor distillation, and the aqueous solution after isolating volatile oil and distilling is subsequent use; Medicinal residues are with Herba Ephedrae, Pericarpium Papaveris, Semen Juglandis extracting in water 2 ~ 3 times, each 2 ~ 4h, merge extractive liquid; Filter, the aqueous solution after filtrating and the distillation merges, and is concentrated into every ml soln and is equivalent to 0.8g ~ 1.5g crude drug; Add alcoholic solution, make to contain alcohol amount and reach 35% ~ 50%, leave standstill; Filter, filtrating concentrate the thick paste I, subsequent use; Semen Armeniacae Amarum squeezing is deoiled back and Fructus Schisandrae Chinensis with 50% ~ 85% ethanol extraction 2 ~ 3 times, each 1 ~ 3h, merge extractive liquid, filters, filtrating concentrated the thick paste II, subsequent use; Above-mentioned thick paste is merged, add acceptable auxiliary on the pharmaceutics, process granule, add Fructus Amomi Rotundus volatile oil again, process tablet or capsule, promptly get.
The relative density of said thick paste I in the time of 70 ℃ is preferably 1.20 ~ 1.40, and the relative density of thick paste II in the time of 70 ℃ is preferably 1.10 ~ 1.25.
Said adjuvant can be selected from one or more in starch, dextrin, mannitol, sorbitol, microcrystalline Cellulose, calcium carbonate, silicon dioxide, the magnesium stearate.
The adding method of said Fructus Amomi Rotundus volatile oil sprays into behind the dissolve with ethanol or with adding after the adsorbents adsorb, wherein adsorbent can be selected from one or more in silicon dioxide, Pulvis Talci, kaolin, calcium hydrogen phosphate, calcium sulfate, the calcium carbonate for adopting.
The present invention innovates part and is to have adopted different extraction processing methods to the different of medical material effective site and effective ingredient.
Fructus Amomi Rotundus among the present invention extracts volatile oil earlier, again with Herba Ephedrae, Pericarpium Papaveris, Semen Juglandis extracting in water, and with the alcohol precipitating method processing, reinstates ethanol extraction with Fructus Schisandrae Chinensis one after the Semen Armeniacae Amarum squeezing is deoiled.The method for preparing of method for preparing provided by the invention and osmanthus spirit ball compares, and not only removed suck tissue such as cellulosic, cork etc. a large amount of in the medical material, also optionally kept the effective ingredient in the medical material through different extraction processing methods.Show also that through clinical verification the Guilin preparation clinical efficacy that adopts method for preparing provided by the invention to make is definite.This shows that method for preparing of the present invention has improved content of effective in the medicine greatly under the prerequisite that guarantees curative effect.
The specific embodiment
Following embodiment is used to explain the present invention, but is not used for limiting scope of the present invention.
Embodiment 1
Herba Ephedrae 400g Pericarpium Papaveris 300g Semen Armeniacae Amarum (stir-fry) 200g Semen Juglandis 200g
Fructus Schisandrae Chinensis 200g Fructus Amomi Rotundus 25g
Above Six-element medical material, Fructus Amomi Rotundus extracts volatile oil with vapor distillation, and the aqueous solution after isolating volatile oil and distilling is subsequent use; Medicinal residues add 10 times of water gagings with Herba Ephedrae, Pericarpium Papaveris, Semen Juglandis and extract 2 times, 4h for the first time, 3h for the second time, merge extractive liquid; Filter, the aqueous solution after filtrating and the distillation merges, and is concentrated into every ml soln and is equivalent to the 1.0g crude drug; Add 80% alcoholic solution, make to contain alcohol amount and reach 45%, hold over night; Filter, filtrating is concentrated into the thick paste that relative density is 1.30 (70 ℃), and is subsequent use; The Semen Armeniacae Amarum squeezing back of deoiling adds 3 times of amount 80% alcohol reflux 2 times with Fructus Schisandrae Chinensis, 2h for the first time, and 1h for the second time, merge extractive liquid, filters, and filtrating is concentrated into the thick paste that relative density is 1.20 (70 ℃), and is subsequent use; Above-mentioned thick paste is merged, add the starch of thick paste weight 10%, mixing, drying is pulverized; Add 200g starch, mixing is used 75% alcohol granulation, drying, granulate; Fructus Amomi Rotundus volatile oil after adding is adsorbed with kaolin and an amount of magnesium stearate, mixing, fill becomes 1000 capsules, promptly gets.
Clinical verification:
1, case is included standard in
(1) meet doctor trained in Western medicine chronic bronchitis (type of panting) diagnosis, and Chinese medical discrimination is the syndrome of yin deficiency of lung and kidney person;
(2) age is in 18 ~ 65 one full year of life;
(3) course of disease≤3 day person;
(4) aspiration is tried, and can accept the checking medicine, keeps accomplishing person's course of treatment.
2, therapeutic scheme
(1) checking medicine
Checking medicine: the embodiment of the invention 1 capsule, every 0.35 gram;
The contrast medicine: osmanthus spirit ball, every ball weighs 6.5 grams.
(2) administrated method
Get into checking group or matched group at random according to table of random number.
The checking group: the embodiment of the invention 1 capsule, one time 4,2 times on the one, oral;
Matched group: osmanthus spirit ball, one time 1 ball, 2 times on the one, oral.
(3) course of treatment
10 days is a course of treatment.
3, therapeutic outcome
(1) comprehensive therapeutic effect
Table 1 liang group efficacy analysis
Group The example number Face control Produce effects Effectively Invalid Obvious effective rate Total effective rate
The checking group 310 108 116 68 18 72.26% 94.19%
Matched group 105 35 40 23 7 71.43% 93.33%
Through rank test, two groups of comprehensive therapeutic effects compare P ﹥ 0.05, there was no significant difference.
(2) Clinical types curative effect
Table 2 liang group Clinical types efficacy analysis
Type Group The example number Face control Produce effects Effectively Invalid Obvious effective rate
Acute attack The checking group 184 71 70 33 10 76.63%
Acute attack Matched group 69 25 27 13 4 75.36%
Chronic delay The checking group 126 37 46 35 8 65.87%
Chronic delay Matched group 36 10 13 10 3 63.89%
Through rank test, two groups of Clinical types curative effects compare P ﹥ 0.05, there was no significant difference.
(3) traditional Chinese medical science disease curative effect
Table 3 liang group traditional Chinese medical science disease efficacy analysis
Group The example number Face control Produce effects Effectively Invalid Obvious effective rate
The checking group 310 111 118 69 12 73.87%
Matched group 105 36 42 22 5 74.29%
Through rank test, two groups of traditional Chinese medical science disease curative effects compare P ﹥ 0.05, there was no significant difference.
(4) cardinal symptom, sign curative effect
Table 4 liang group individual event symptoms and therapeutic effect
Cardinal symptom Group The example number Face control Produce effects Effectively Invalid Obvious effective rate
Cough The checking group 310 ?111 ?118 ?69 ?12 ?73.87%
Cough Matched group 105 ?38 40? ?21 6 ?74.29%
Cough up phlegm The checking group 141 ?45 ?55 ?34 ?7 ?70.92%
Cough up phlegm Matched group 47 ?14 ?19 ?11 ?3 ?70.21%
Pant The checking group 310 ?109 ?117 ?70 ?14 ?72.90%
Pant Matched group 105 ?37 ?39 ?24 ?5 ?72.38%
Wheezing The checking group 310 ?109 ?115 ?70 ?16 ?72.26%
Wheezing Matched group 105 ?36 ?39 ?25 ?5 ?71.43%
Through rank test, two groups of individual event symptom curative effects compare P ﹥ 0.05, there was no significant difference.
Table 5 liang group treatment back symptom and sign integration relatively
Symptom and sign The example number The checking group (X ± S) The example number Matched group (X ± S)
Cough 310 0.91±0.70 105 0.90±0.71
Cough up phlegm 310 0.22±0.38 105 0.21±0.38
Pant 310 0.90±0.70 105 0.89±0.70
Wheezing 310 0.91±0.70 105 0.87±0.69
Heating 310 0.20±0.29 105 0.19±0.28
Dry mouth and throat 310 0.82±0.68 105 0.83±0.68
Spontaneous perspiration 310 0.81±0.68 105 0.79±0.67
Easy catching a cold 310 0.74±0.64 105 0.72±0.65
Breathe hard 310 0.70±0.63 105 0.71±0.65
Through the t check, two groups of treatment back symptom and sign integrations compare P ﹥ 0.05, there was no significant difference.
(5) safety
During verifying, all do not find obvious adverse reaction for two groups, security inspection does not have yet to be treated normally preceding and case that the treatment back is unusual.
4, sum up
Clinical results shows: the embodiment of the invention 1 capsule for treating chronic bronchitis (type of panting) total effective rate is 94.19%, and obvious effective rate is 72.26%.Compare with matched group, through statistical procedures, there was no significant difference.Do not find obvious toxic and side effects and untoward reaction yet.
Embodiment 2
Herba Ephedrae 400g Pericarpium Papaveris 300g Semen Armeniacae Amarum (stir-fry) 200g Semen Juglandis 200g
Fructus Schisandrae Chinensis 200g Fructus Amomi Rotundus 25g
Above Six-element medical material, Fructus Amomi Rotundus extracts volatile oil with vapor distillation, and the aqueous solution after isolating volatile oil and distilling is subsequent use; Medicinal residues add 10 times of water gagings with Herba Ephedrae, Pericarpium Papaveris, Semen Juglandis and extract 2 times, 4h for the first time, 2h for the second time, merge extractive liquid; Filter, the aqueous solution after filtrating and the distillation merges, and is concentrated into every ml soln and is equivalent to the 0.8g crude drug; Add 95% alcoholic solution, make to contain alcohol amount and reach 35%, hold over night; Filter, filtrating is concentrated into the thick paste that relative density is 1.40 (70 ℃), and is subsequent use; The Semen Armeniacae Amarum squeezing back of deoiling adds 4 times of amount 85% alcohol reflux 2 times with Fructus Schisandrae Chinensis, 2h for the first time, and 1h for the second time, merge extractive liquid, filters, and filtrating is concentrated into the thick paste that relative density is 1.25 (70 ℃), and is subsequent use; Above-mentioned thick paste is merged, add 250g starch and 10g silicon dioxide, mixing, granulation, drying, granulate, Fructus Amomi Rotundus volatile oil spray into after with dissolve with ethanol, and mixing adds an amount of magnesium stearate, and mixing is pressed into 1000, and sugar coating or film-coat promptly get.
Embodiment 3
Herba Ephedrae 400g Pericarpium Papaveris 300g Semen Armeniacae Amarum (stir-fry) 200g Semen Juglandis 200g
Fructus Schisandrae Chinensis 200g Fructus Amomi Rotundus 25g
Above Six-element medical material, Fructus Amomi Rotundus extracts volatile oil with vapor distillation, and the aqueous solution after isolating volatile oil and distilling is subsequent use; Medicinal residues add 8 times of water gagings with Herba Ephedrae, Pericarpium Papaveris, Semen Juglandis and extract 3 times, each 2h, merge extractive liquid; Filter, the aqueous solution after filtrating and the distillation merges, and is concentrated into every ml soln and is equivalent to the 1.5g crude drug; Add 70% alcoholic solution, make to contain alcohol amount and reach 50%, hold over night; Filter, filtrating is concentrated into the thick paste that relative density is 1.20 (70 ℃), and is subsequent use; After deoiling, the Semen Armeniacae Amarum squeezing adds 3 times of amount 50% alcohol reflux 3 times with Fructus Schisandrae Chinensis, each 1h, and merge extractive liquid, filters, and filtrating is concentrated into the thick paste that relative density is 1.10 (70 ℃), and is subsequent use; Above-mentioned thick paste is merged, add the 100g dextrin, mixing, drying is pulverized, and adds 120g dextrin and 30g mannitol, uses 85% alcohol granulation, and drying adds with the Fructus Amomi Rotundus volatile oil after the silicon dioxide absorption, mixing, fill becomes 1000 capsules, promptly gets.
Embodiment 4
Herba Ephedrae 400g Pericarpium Papaveris 300g Semen Armeniacae Amarum (stir-fry) 200g Semen Juglandis 200g
Fructus Schisandrae Chinensis 200g Fructus Amomi Rotundus 25g
Above Six-element medical material, Fructus Amomi Rotundus extracts volatile oil with vapor distillation, and the aqueous solution after isolating volatile oil and distilling is subsequent use; Medicinal residues add 8 times of water gagings with Herba Ephedrae, Pericarpium Papaveris, Semen Juglandis and extract 3 times, each 2h, merge extractive liquid; Filter, the aqueous solution after filtrating and the distillation merges, and is concentrated into every ml soln and is equivalent to the 1.5g crude drug; Add 70% alcoholic solution, make to contain alcohol amount and reach 40%, hold over night; Filter, filtrating is concentrated into the thick paste that relative density is 1.40 (70 ℃), and is subsequent use; After deoiling, the Semen Armeniacae Amarum squeezing adds 2 times of amount 85% alcohol reflux 2 times with Fructus Schisandrae Chinensis, each 3h, and merge extractive liquid, filters, and filtrating is concentrated into the thick paste that relative density is 1.10 (70 ℃), and is subsequent use; Above-mentioned thick paste is merged, add 40g calcium carbonate, 200g starch and 5g silicon dioxide, mixing is granulated, drying, and granulate adds with Fructus Amomi Rotundus volatile oil after the calcium hydrogen phosphate absorption and an amount of Pulvis Talci, and mixing is pressed into 1000, and sugar coating or film-coat promptly get.

Claims (6)

1. the method for preparing of a Guiling preparation, described Guiling preparation is processed by Herba Ephedrae, Pericarpium Papaveris, Semen Armeniacae Amarum (stir-fry), Semen Juglandis, Fructus Schisandrae Chinensis, Fructus Amomi Rotundus, it is characterized in that method for preparing comprises the steps:
A, Fructus Amomi Rotundus adopt vapor distillation to extract volatile oil, and the aqueous solution after isolating volatile oil and distilling is subsequent use;
B, Fructus Amomi Rotundus medicinal residues are with Herba Ephedrae, Pericarpium Papaveris, Semen Juglandis extracting in water 2 ~ 3 times, each 2 ~ 4h, merge extractive liquid; Filter, the aqueous solution after filtrating is distilled with the A step merges, and is concentrated into every ml soln and is equivalent to 0.8g ~ 1.5g crude drug; Add alcoholic solution, make to contain alcohol amount and reach 35% ~ 50%, leave standstill; Filter, filtrating concentrate the thick paste I, subsequent use;
The squeezing of C, Semen Armeniacae Amarum is deoiled back and Fructus Schisandrae Chinensis with 50% ~ 85% ethanol extraction 2 ~ 3 times, each 1 ~ 3h, merge extractive liquid, filters, filtrating concentrated the thick paste II, subsequent use;
D, above-mentioned thick paste I and II are merged, add acceptable auxiliary on the pharmaceutics, process granule, add Fructus Amomi Rotundus volatile oil, process tablet or capsule, promptly get.
2. method for preparing as claimed in claim 1 is characterized in that the parts by weight of each medical material are respectively: 400 parts in Herba Ephedrae, 300 parts of Pericarpium Papaveriss, 200 parts of Semen Armeniacae Amarums (stir-fry), 200 parts of Semen Juglandis, 200 parts of Fructus Schisandrae Chinensis, 25 parts in Fructus Amomi Rotundus.
3. method for preparing as claimed in claim 1 is characterized in that: the relative density of thick paste I in the time of 70 ℃ is 1.20 ~ 1.40, and the relative density of thick paste II in the time of 70 ℃ is 1.10 ~ 1.25.
4. method for preparing as claimed in claim 1 is characterized in that said adjuvant is selected from one or more in starch, dextrin, mannitol, sorbitol, microcrystalline Cellulose, calcium carbonate, silicon dioxide, the magnesium stearate.
5. method for preparing as claimed in claim 1 is characterized in that: Fructus Amomi Rotundus volatile oil sprays into after with dissolve with ethanol or with adding after the adsorbents adsorb.
6. method for preparing as claimed in claim 5 is characterized in that described adsorbent is selected from one or more in silicon dioxide, Pulvis Talci, kaolin, calcium hydrogen phosphate, calcium sulfate, the calcium carbonate.
CN2012100744830A 2012-03-21 2012-03-21 Preparation method of guiling preparation Active CN102688435B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012100744830A CN102688435B (en) 2012-03-21 2012-03-21 Preparation method of guiling preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012100744830A CN102688435B (en) 2012-03-21 2012-03-21 Preparation method of guiling preparation

Publications (2)

Publication Number Publication Date
CN102688435A true CN102688435A (en) 2012-09-26
CN102688435B CN102688435B (en) 2013-12-11

Family

ID=46854279

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012100744830A Active CN102688435B (en) 2012-03-21 2012-03-21 Preparation method of guiling preparation

Country Status (1)

Country Link
CN (1) CN102688435B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111317803A (en) * 2018-12-14 2020-06-23 康普药业股份有限公司 Adsorption method of Ganfule volatile oil
CN113509533A (en) * 2020-04-09 2021-10-19 吉林省利华制药有限公司 Guiling tablet medicine composition and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1742977A (en) * 2005-09-23 2006-03-08 北京阜康仁生物制药科技有限公司 Guiling preparation and new preparing method
CN101181517A (en) * 2007-12-04 2008-05-21 朱惠芬 Chinese medicine medicinal granules for tonifying lung and relieving cough
CN102145113A (en) * 2010-02-04 2011-08-10 天津中新药业集团股份有限公司达仁堂制药厂 Chinese medical composition capable of resolving phlegm and relieving asthma and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1742977A (en) * 2005-09-23 2006-03-08 北京阜康仁生物制药科技有限公司 Guiling preparation and new preparing method
CN101181517A (en) * 2007-12-04 2008-05-21 朱惠芬 Chinese medicine medicinal granules for tonifying lung and relieving cough
CN102145113A (en) * 2010-02-04 2011-08-10 天津中新药业集团股份有限公司达仁堂制药厂 Chinese medical composition capable of resolving phlegm and relieving asthma and preparation method thereof

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
于荣敏: "罂粟科植物的化学成分及药理作用研究进展", 《上海中医药杂志》, vol. 38, no. 7, 31 July 2004 (2004-07-31), pages 59 - 61 *
付善良等: "北五味子和南五味子化学成分的比较分析", 《药物分析杂杂志》, vol. 29, no. 4, 30 April 2009 (2009-04-30), pages 524 - 531 *
孟洁等: "核桃仁活性成分的提取及体外抗氧化活性研究", 《食品科学》, vol. 22, no. 12, 30 December 2001 (2001-12-30), pages 44 - 47 *
李科友等: "苦杏仁化学成分的研究", 《西北林学院学报》, vol. 19, no. 2, 31 May 2004 (2004-05-31), pages 124 - 126 *
沈红等: "不同提取方法对麻黄中麻黄碱提取得率的比较研究", 《南京中医药大学学报》, vol. 20, no. 3, 30 June 2004 (2004-06-30), pages 170 - 172 *
王秀芹等: "草豆蔻化学成分研究", 《中药材》, vol. 31, no. 6, 30 June 2008 (2008-06-30), pages 853 - 855 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111317803A (en) * 2018-12-14 2020-06-23 康普药业股份有限公司 Adsorption method of Ganfule volatile oil
CN113509533A (en) * 2020-04-09 2021-10-19 吉林省利华制药有限公司 Guiling tablet medicine composition and preparation method thereof

Also Published As

Publication number Publication date
CN102688435B (en) 2013-12-11

Similar Documents

Publication Publication Date Title
WO2012027882A1 (en) Pharmaceutical composition for treating insomnia and preparation method thereof
CN104666373A (en) Novel use of Eurycoma longifolia Jack
CN102631579B (en) Oral Chinese herbal preparation for treating post-traumatic brain syndrome
CN104225006A (en) Traditional Chinese medicine composition capable of invigorating Qi and relaxing bowels
CN107648479B (en) Traditional Chinese medicine formula for treating hypertension and product thereof
CN102688435B (en) Preparation method of guiling preparation
CN103156930A (en) Respiratory tract dosing preparation containing extract of paeonia lactiflora and licorice
CN103006831B (en) Blood platelet raising capsules, namely Chinese herbal combination, and preparation method of capsules
CN102895387A (en) Kidney-yang-warming medicine composition, and preparation thereof and preparation method thereof
CN105727104A (en) Medicine composition with effects of diminishing inflammation and relieving cough and method for preparing medicine composition
CN105125616A (en) Traditional Chinese medicine composition having function of improving anoxia endurance
CN101664461B (en) Pharmaceutical composition for treating cough
CN1943637B (en) Medicine for eliminating sputum and relieving asthma and its preparing method
CN104857393A (en) Pharmaceutical preparation for treating arrhythmia
CN104491483A (en) Traditional Chinese medicine composition for improving allergic diseases, preparation method and application thereof
CN102198162B (en) Traditional Chinese medicine composition for treating coronary heart disease, and preparation method thereof
CN112076276B (en) Pharmaceutical composition for treating allergic rhinitis and preparation method thereof
CN104189833A (en) Process for preparing xiaoyao pills
CN102743456B (en) The application of a kind of Chinese medicine composition in the medicine of preparation control delayed encephalopathy after acute carbon monoxide poisoning
CN107753551B (en) Composition with function of reducing blood pressure and preparation method thereof
CN102895513B (en) Application of Chinese medicine composition in preparing medicines for treating viral myocarditis
CN108606996A (en) It is a kind of that there is the pharmaceutical composition for improving immune function
CN105079394A (en) Pharmaceutic preparation for treating arrhythmia
CN106466396A (en) A kind of Fuke Tiaojing sustained-release dropping pill and preparation method thereof
CN104435845A (en) Preparation method of externally-applied nursing articles for treating graves disease in pregnancy

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CP03 Change of name, title or address
CP03 Change of name, title or address

Address after: 335200 north of national highway 320, Jiaotong North Road, Yujiang District, Yingtan City, Jiangxi Province

Patentee after: Jiangxi Kangenbei tianshikang Pharmaceutical Co.,Ltd.

Address before: Five industrial road, Yingtan Industrial Zone, Jiangxi 335000, China

Patentee before: Jiangxi Herbi-Sky Co.,Ltd.